Dexamethasone/pembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1970卷 / 1期

关键词：

D O I：

10.1007/s40278-023-44957-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：116 / 116

相关论文

共 50 条

[41] Catequentinib/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 138 - 138
[42] Entinostat/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 595 - 595
[43] Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 759 - 759
[44] Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1935 (1) : 347 - 347
[45] Dexamethasone/lisinopril/pembrolizumabLack of efficacy
Reactions Weekly, 2024, 2004 (1) : 168 - 168
[46] Dacarbazine/pembrolizumabLack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 170 - 170
[47] PembrolizumabLack of efficacy and hypothyroidism: case report
Reactions Weekly, 2023, 1950 (1) : 330 - 330
[48] Cabozantinib/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2041 (1) : 92 - 92
[49] Antineoplastics/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1919 (1) : 91 - 91
[50] Paclitaxel/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 403 - 403

← 1 2 3 4 5 →